Qualitative study on perceptions of use of Fractional Exhaled Nitric Oxide (FeNO) in asthma reviews
Open Access
- 21 March 2022
- journal article
- review article
- Published by Springer Nature in npj Primary Care Respiratory Medicine
- Vol. 32 (1) , 1-6
Abstract
Current methods to assess asthma and guide inhaled corticosteroid (ICS) dose titration mainly centre on patient-reported symptoms and lung function assessments. However, these methods correlate only weakly with airway inflammation making them unreliable predictors of future exacerbations and ICS requirement. Fractional Exhaled Nitric Oxide (FeNO) is a simple non-invasive objective measure of airways inflammation used predominantly in specialist clinics. Previous qualitative studies have mainly focused on the acceptability of FeNO in secondary care and there is limited insight to support clinicians and patients using FeNO in primary care asthma reviews. This study aimed to explore adult patient with asthma and primary care health care professional (HCP) views on introducing FeNO as part of routine asthma reviews. Twenty-three health care professionals and 22 patients were interviewed over the phone or online. Both groups reported that current asthma reviews are often seen as tick-box exercises and that introducing the FeNO test would make reviews more tailored to the individual patient, rather than relying on subjective patient reports of asthma control. Adults with asthma also highlighted support more open communication and their understanding of asthma, as they desired to feel more engaged in decisions and conversations about their asthma. HCPs reported valuing patient education and empowerment over a paternalistic approach, when time and resources allow. They also recognised FeNO to provide an objective measure of inflammation that could support them in the education and empowerment of patients. FeNO was seen by both groups as a potentially valuable addition to current asthma reviews mainly led by nurses, both for increasing their understanding of current risk of exacerbation and also to provide more tailored and personalised asthma management to patients. Our findings highlighted the need for open and clear communication about how to interpret FeNO results.Keywords
Funding Information
- DH | National Institute for Health Research (RP-PG-0618-20002, RP-PG-0618-20002, RP-PG-0618-20002, RP-PG-0618-20002, RP-PG-0618-20002, RP-PG-0618-20002, RP-PG-0618-20002)
This publication has 20 references indexed in Scilit:
- Why aren’t we doing better in asthma: time for personalised medicine?npj Primary Care Respiratory Medicine, 2015
- Thematic Analysis2014
- Exhaled nitric oxide levels and blood eosinophil counts independently associate with wheeze and asthma events in National Health and Nutrition Examination Survey subjectsJournal of Allergy and Clinical Immunology, 2013
- Assessing the risk of attack in the management of asthma: a review and proposal for revision of the current control-centred paradigmPrimary Care Respiratory Journal, 2013
- A cross-sectional study of patterns of airway dysfunction, symptoms and morbidity in primary care asthmaPrimary Care Respiratory Journal, 2012
- Communication between nurses, children and their parents in asthma review consultationsJournal of Clinical Nursing, 2012
- Outcomes using exhaled nitric oxide measurements as an adjunct to primary care asthma managementPrimary Care Respiratory Journal, 2009
- Factibilidad de la medición en atención primaria de la fracción exhalada de óxido nítrico en niños con asma. Estudio CANONAnales de Pediatría, 2009
- The use of exhaled nitric oxide monitoring in primary care asthma clinics: a pilot studyPrimary Care Respiratory Journal, 2007
- Relationship Between Airway Obstruction and Respiratory Symptoms in Adult AsthmaticsChest, 1998